[{"id":"3be9f507-67a2-4cb7-a07b-b039d2c87116","acronym":"","url":"https://clinicaltrials.gov/study/NCT05164666","created_at":"2021-12-21T16:53:48.131Z","updated_at":"2024-07-02T16:35:25.177Z","phase":"Phase 1","brief_title":"A Study of TAK-103 in Adult With Solid Tumors","source_id_and_acronym":"NCT05164666","lead_sponsor":"Takeda","biomarkers":" MSLN","pipe":" | ","alterations":" MSLN expression","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NIB103"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 2","initiation":"Initiation: 01/05/2022","start_date":" 01/05/2022","primary_txt":" Primary completion: 10/31/2027","primary_completion_date":" 10/31/2027","study_txt":" Completion: 10/31/2027","study_completion_date":" 10/31/2027","last_update_posted":"2023-12-27"}]